Linaclotide
Product Specifications
CAS Number
851199-59-2
Target
Guanylate cyclase
Related Pathways
GPCR/G Protein
Purity
0.9871
Bioactivity
Linaclotide, developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation, is a potent and selective guanylate cyclase C agonist.
Smiles
C[C@@H](O)C1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CCC(O)=O)NC3=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N2
Molecular Formula
C59H79N15O21S6
Molecular Weight
1526.74
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15274350 1 Vial
Lentiviral mouse Peg12 shRNA (UAS) - Lentiviral mouse Peg12 shRNA (UAS) (100)
Sign In for Pricing
View Details 